Evidence map›Paper›PMID 41065255›Full record

ArticleJournal of the American Heart Association2025

Prolonged Postnatal Hypoxia Impairs Lung Development and Causes Severe Pulmonary Hypertension in Mice.

Luca Zazzeron, Kakeru Shimoda, Paul Lichtenegger, Elizabeth Moore, Helena Tattersfield, Alexandra K Marenco, Jiayi Kang, Haobo Li, Eizo Marutani, Donald B Bloch and 1 more

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Lifelong hypoxia produces multigenerational developmental lung disease and pulmonary hypertension in mice.American journal of physiology. Lung cellular and molecular physiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Nutrients · 2026
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Luca ZazzeronAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine Massachusetts General Hospital and Harvard Medical School Boston MA USA.ORCID 0000-0001-9169-1262
Kakeru ShimodaAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine Massachusetts General Hospital and Harvard Medical School Boston MA USA.ORCID 0000-0002-6984-9016
Paul LichteneggerAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine Massachusetts General Hospital and Harvard Medical School Boston MA USA.ORCID 0000-0002-3171-794X
Elizabeth MooreAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine Massachusetts General Hospital and Harvard Medical School Boston MA USA.
Helena TattersfieldAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine Massachusetts General Hospital and Harvard Medical School Boston MA USA.
Alexandra K MarencoAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine Massachusetts General Hospital and Harvard Medical School Boston MA USA.ORCID 0009-0005-2552-2627
Jiayi KangDepartment of Anesthesia, Critical Care, and Pain Medicine Massachusetts General Hospital and Harvard Medical School Boston MA USA.
Haobo LiDepartment of Anesthesia, Critical Care, and Pain Medicine Massachusetts General Hospital and Harvard Medical School Boston MA USA.ORCID 0000-0002-5660-7835
Eizo MarutaniAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine Massachusetts General Hospital and Harvard Medical School Boston MA USA.
Donald B BlochAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine Massachusetts General Hospital and Harvard Medical School Boston MA USA.ORCID 0000-0002-6828-4754
Fumito IchinoseAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine Massachusetts General Hospital and Harvard Medical School Boston MA USA.ORCID 0000-0003-4535-1632

Funding

Research Training for AnesthetistsT32GM007592 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI STUART A FORMAN · 1985 to 2026
$11.8M
METTL3 in Cardiac Benefits of Exercise in DiabetesR01HL171201 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Haobo Li · 2024 to 2026
$1.8M
The Role of SALTe1 in Vascular Aging and Heart Failure With Preserved Ejection FractionR01HL169272 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Haobo Li · 2025 to 2026
$1.4M
NHLBI NIH HHS R01 HL169272NHLBI NIH HHS R01 HL171201NIGMS NIH HHS T32 GM007592
6 · The paper itself

Abstract

backgroundIn children born at high altitude, lung development is affected by hypoxia, which can lead to pulmonary hypertension and right ventricular failure. Animal models of postnatal, transient, hypoxia failed to reproduce these conditions seen in children living at high altitude. The aim of this study was to establish a mouse model of pediatric pulmonary hypertension associated with abnormal lung development.

methodsC57bl/6J mice were exposed to normobaric hypoxia at 11% inspired fraction of oxygen starting on postnatal-days 1 to 4 ("11%-birth"). At age 8 weeks, pulmonary arterial pressure and right ventricular function were assessed using echocardiography and invasive hemodynamics. The physiology and the structure of lung parenchyma and vasculature were assessed through evaluations of gas exchange, respiratory mechanics, and histopathology. Results were compared with control mice breathing 21% inspired fraction of oxygen for 8 weeks (21%-birth), and to adult mice breathing 11% inspired fraction of oxygen for 8 weeks (11%-adult).

resultsSeventy percent of 11%-birth mice survived until age 8 weeks; the mice subsequently experienced a steady decline in survival, with a median lifespan of 150 days. Mice that survived for 8 weeks had evidence of impaired lung development, such as alveolar and vascular simplification with muscularization of small pulmonary vessels, impaired gas exchange, and altered respiratory mechanics. These changes were associated with reduced exercise capacity, severe pulmonary hypertension, and right ventricular failure. Adult mice subjected to chronic hypoxia had mild changes in the pulmonary vasculature resulting in mild pulmonary hypertension without right ventricular dysfunction.

conclusionsThis mouse model of prolonged hypoxia beginning early after birth offers a novel approach to explore treatments for pediatric pulmonary hypertension linked to abnormalities in lung development.

Indexed as

Hypertension, PulmonaryHypoxiaLungAge FactorsAnimalsAnimals, NewbornDisease Models, AnimalMaleMiceMice, Inbred C57BLSeverity of Illness IndexTime FactorsVentricular Function, Rightbronchopulmonary dysplasiahypoxiapediatric pulmonary hypertensionpulmonary hypertensionright ventricular dysfunction

Identifiers

PMID41065255
PMCPMC12684492

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.